Disclosures: Leidy Estefania Zapata-Pavas: Nothing to Disclose, Marina Serrano-Macia: Nothing to Disclose, Miguel ngel Merlos Rodrigo: Nothing to Disclose, Patricia Pea-SanFelix: Nothing to Disclose, Cludia Gil-Pitarch: Nothing to Disclose, Naroa Goikoetxea-Usandizaga: Nothing to Disclose, Hana Michalkova: Nothing to Disclose, Zbynek Heger: Nothing to Disclose, lvaro del Ro-lvarez: Nothing to Disclose, Laura Royo: Nothing to Disclose, Claudia M
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist with FDA-approved indications: Mounjaro for type 2 diabetes management and Zepbound for chronic weight management
How Ozempic and Other Semaglutides Work Ozempic is a glucagon-like peptide-1 receptor agonist (GLP-1, or sometimes GLP-1 RA)
Are there side effects I should know about with compounded semaglutide
While plaintiffs push for access to Novo Nordisks internal safety records and adverse event data, the defense is expected to challenge claims regarding medical causation